IPP Bureau
Suraksha Diagnostic reports Q1 FY26 PAT higher by 20% at Rs. 9.1 Cr
By IPP Bureau - August 09, 2025
Hikal reports Q1 FY26 consolidated loss of Rs. 22.4 Cr
By IPP Bureau - August 08, 2025
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Sigachi begins construction work for MCC capacity expansion at Dahej
By IPP Bureau - August 08, 2025
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
Metropolis Healthcare reports Q1 FY26 PAT higher by 19% at Rs. 45 Cr
By IPP Bureau - August 08, 2025
ekincare launches elva.AI to resolve 80% of employee healthcare queries
By IPP Bureau - August 08, 2025
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
Quest Diagnostics completes acquisition of Spectra Laboratories’ Clinical Testing Assets from Fresenius Medical Care
By IPP Bureau - August 08, 2025
Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
Primelaze introduces Q-Switched Nd:YAG laser technology in India for skin treatments
By IPP Bureau - August 08, 2025
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
IOL Chemicals post Q1 FY26 consolidated profit at Rs. 33.93 Cr
By IPP Bureau - August 08, 2025
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Caplin Point Laboratories posts Q1 FY26 consolidated PAT at Rs. 152.80 Cr
By IPP Bureau - August 08, 2025
Caplin Point Laboratories has reported total income of Rs. 533.36 crores during the period ended June 30, 2025
ZIM Laboratories granted marketing authorization for Tamsulosin + Dutasteride capsules in Australia
By IPP Bureau - August 08, 2025
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
WACKER and Gearbox Biosciences collaborate to advance pDNA manufacturing technologies
By IPP Bureau - August 08, 2025
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Biocon Q1 FY26 PAT slips 95% to Rs. 31.4 Cr
By IPP Bureau - August 08, 2025
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
By IPP Bureau - August 07, 2025
This is the group’s first NoC approval in Canada
Indegene posts Q1 net profit higher by 33% YoY to Rs. 116.4 Cr
By IPP Bureau - August 06, 2025
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
Alembic Pharmaceuticals Q1 FY26 revenue up 10%; Net profit up 15%
By IPP Bureau - August 06, 2025
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
